Clinical Trial Update: Efficacy and Safety of ALGRX 4975 in Treatment of Postoperative Pain After Hernia Repair [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of ALGRX 4975 for postoperative pain after hernia repair, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• ALGRX 4975

Snippet

Sponsor: AlgoRx Pharmaceuticals | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED